1,3,5-Tri-O-benzoyl-a-D-ribofuranose
1,3,5-Tri-O-benzoyl-a-D-ribofuranose is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[22224-41-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/1-3-5-tri-o-benzoyl-a-d-ribofuranose.html
Purity
99.75
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC=C1)OC[C@H]2O[C@H](OC(C3=CC=CC=C3)=O)[C@H](O)[C@@H]2OC(C4=CC=CC=C4)=O
Molecular Formula
C26H22O8
Molecular Weight
462.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Canine IgG1, lambda Isotype Control antibody (HyHEL-10)
Canine IgG1, lambda Isotype Control antibody (HyHEL-10)
Canine IgG1, lambda Isotype Control antibody (HyHEL-10)